S. Vogl

发表

Combination chemotherapy for advanced colorectal cancer with triazinate, ICRF-159, 5-FU, and methyl-CCNU.

S. Vogl, R. Qazi, M. Berenzweig, 1980, Cancer treatment reports.

An application of immunocytology to the analysis of the cell kinetics of upper respiratory and digestive tract squamous carcinoma

R. Bases, S. Vogl, P. Hebbard, 1983, Cancer.

Recurrent ovarian carcinoma: retreatment utilizing combination chemotherapy including cis-diamminedichloroplatinum in patients previously responding to this agent.

S. Vogl, V. Seltzer, B. Kaplan, 1985, Gynecologic oncology.

Mitomycin‐C, methotrexate, bleomycin and cis‐diamminedichloroplatinum II in the chemotherapy of advanced squamous cancer of the head and neck

D. Schoenfeld, H. Lerner, S. Vogl, 1982, Cancer.

Ovarian cancer: diagnostic second laparotomy and salvage intra-peritoneal chemotherapy fail again.

S. Vogl, 1995, European journal of cancer.

Chemotherapy of advanced head and neck cancer with methotrexate, bleomycin, and cis‐diamminedichloroplatinum II in an effective outpatient schedule

S. Vogl, B. Kaplan, 1979, Cancer.

Adjuvant bisphosphonates for resected breast cancer: Not quite yet

C. Poznak, S. Vogl, 2014 .

Cis‐platin based combination chemotherapy for advanced ovarian cancer. High overall response rate with curative potential only in women with small tumor burdens

J. Arseneau, S. Vogl, B. Kaplan, 1983, Cancer.

Phase II study of mitoguazone, cyclophosphamide, doxorubicin, vincristine and prednisone for patients with diffuse histologic subtypes of non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Study (PE481).

M. Oken, D. Moore, J. Glick, 1998, Leukemia & lymphoma.

A randomized phase II study of m‐AMSA (NSC 249992) and neocarzinostatin (NSC 157365) in non‐small cell broncliogenic carcinoma: An Eastern Cooperative Group Study

R. Day, D. Ettinger, J. Ruckdeschel, 1983, American Journal of Clinical Oncology.

MACC chemotherapy for adenocarcinoma and epidermoid carcinoma of the lung. Low response rate in a cooperative group study

Martin H. Cohen, C. Mehta, S. Vogl, 1979, Cancer.

Combination chemotherapy with adriamycin and cis‐diamminedichloroplatinum in patients with neoplastic diseases

J. Holland, M. Perloff, T. Ohnuma, 1976, Cancer.

“Second‐effort” surgical resection for bulky ovarian cancer

S. Vogl, V. Seltzer, F. Camacho, 1984, Cancer.

Is there cumulative or delayed toxicity from Cis‐platinum?

S. Vogl, F. Camacho, B. Kaplan, 1983, Cancer.

Intraperitoneal cisplatin with intravenous cyclophosphamide and doxorubicin for previously untreated stage III and IV ovarian carcinoma.

J. Young, S. Vogl, F. Garretson, 1989, Cancer investigation.

Chemotherapy for advanced cervical cancer with bleomycin, vincristine, mitomycin C, and cis-diamminedichloroplatinum(II) (BOMP).

S. Vogl, B. Kaplan, M. Moukhtar, 1980, Cancer treatment reports.

Characterization of patients who received further adjuvant endocrine therapy after 5 years of aromatase inhibitors (AIs): NCIC CTG MA 27.

P. Goss, J. Chapman, L. Shepherd, 2012 .

Sequential methotrexate and 5‐fluorouracil with bleomycin and cisplatin in the chemotherapy of advanced squamous cancer of the head and neck

P. Engstrom, F. Muggia, H. Lerner, 1986, Cancer.

Efficacy study of intensive cis‐platin therapy in advanced non‐small cell bronchogenic carcinoma

S. Vogl, M. Berenzweig, F. Camacho, 1982, Cancer.

Effective chemotherapy for esophageal cancer with methotrexate, bleomycin, and cis‐diamminedichloroplatinum II

S. Vogl, B. Kaplan, E. Greenwald, 1981, Cancer.

High-dose megestrol acetate in the treatment of patients with ovarian cancer who have undergone previous treatment: Eastern Cooperative Oncology Group Study PD884.

H. Ball, P. Wiernik, J. Young, 1998, American journal of clinical oncology.

Cervical cysts: Cancer until proven otherwise?

C. Silver, S. Vogl, J. Cinberg, 1982, The Laryngoscope.

Methotrexate alone or with regional subcutaneous corynebacterium parvum in the treatment of recurrent and metastatic squamous cancer of the head and neck

D. Schoenfeld, J. Horton, H. Lerner, 1982, Cancer.

Failure of effective initial chemotherapy to modify the course of stage IV (MO) squamous cancer of the head and neck

H. Lerner, B. McCormick, S. Vogl, 1982, Cancer.

Acute leukemia complicating treatment of glioblastoma multiforme

S. Vogl, 1978, Cancer.

Phase II trial of misonidazole (MISO) and cyclophosphamide (CYC) in metastatic renal cell carcinoma.

L. Kvols, D. Trump, P. Elson, 1986, International journal of radiation oncology, biology, physics.

Phase II trials of 5-day vinblastine infusion (NSC 49842), L-alanosine (NSC 153353), acivicin (NSC 163501), and aminothiadiazole (NSC 4728) in patients with recurrent or metastatic renal cell carcinoma

J. Earle, L. Kvols, D. Trump, 1988, Investigational New Drugs.

Myeloma of the head of the pancreas. A case report

M. Suhrland, S. Vogl, A. Fischer, 1991, Cancer.

A phase II trial of carboplatin (NSC 241240) in advanced prostate cancer, refractory to hormonal therapy

L. Kvols, D. Trump, R. Hahn, 1990, Investigational New Drugs.

Chemotherapy for advanced cervical cancer with methotrexate, bleomycin, and cis-dichlorodiammineplatinum(II).

S. Vogl, B. Kaplan, M. Moukhtar, 1979, Cancer treatment reports.

A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.

D. Ettinger, D. Finkelstein, J. Ruckdeschel, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized trial of initial therapy with melphalan versus cisplatin‐based combination chemotherapy in patients with advanced ovarian carcinoma: Initial and long term results—Eastern Cooperative Oncology Group study E2878

B. Yeap, S. Wadler, P. Carbone, 1996, Cancer.

Hexamethylmelamine and low or moderate dose cisplatin with or without pyridoxine for treatment of advanced ovarian carcinoma: a study of the Eastern Cooperative Oncology Group.

B. Yeap, J. Horton, G. Falkson, 1992, Cancer investigation.

Cisplatin, carboplatin, and cyclophosphamide combination chemotherapy in advanced-stage ovarian carcinoma: an Eastern Cooperative Oncology Group pilot study.

J. Grem, P. O'dwyer, D. Trump, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

RANDOMIZED PHASE II EVALUATION OF CARBOPLATIN AND CHIP IN ADVANCED TRANSITIONAL CELL CARCINOMA OF THE UROTHELIUM

D. Trump, R. Hahn, P. Elson, 1990 .

Toxicity of Cis‐diamminedichloroplatinum II given in a two‐hour outpatient regimen of diuresis and hydration

S. Vogl, B. Kaplan, T. Zaravinos, 1980, Cancer.

Hexamethylmelamine and cisplatin in advanced ovarian cancer after failure of alkylating-agent therapy.

J. Arseneau, N. Einhorn†, T. E. Davis, 1982, Cancer treatment reports.

Sequential chemotherapy of advanced colorectal cancer with standard or high-dose methotrexate followed by 5-fluorouracil.

S. Vogl, M. Berenzweig, R. Lanham, 1982, Medical and pediatric oncology.

A randomized prospective comparison of methotrexate with a combination of methotrexate, bleomycin, and cisplatin in head and neck cancer

P. Engstrom, D. Schoenfeld, J. Horton, 1985, Cancer.

Hydroxyurea fails to improve the results of MBD chemotherapy in cancer of the head and neck, but reduces toxicity

H. Lerner, S. Vogl, F. Camacho, 1983, Cancer.

Safe and effective two-hour outpatient regimen of hydration and diuresis for the administration of cis-diamminedichloroplatinum (II).

S. Vogl, B. Kaplan, D. Wollner, 1981, European journal of cancer.

Effective outpatient combination chemotherapy for advanced cancer of the head and neck.

S. Vogl, B. Kaplan, D. Chiuten, 1980, Surgery, gynecology & obstetrics.

The CHAD and HAD regimens in advanced ovarian cancer: combination chemotherapy including cyclophosphamide, hexamethylmelamine, adriamycin, and cis-dichlorodiammineplatinum(II).

S. Vogl, M. Berenzweig, W. Bulkin, 1979, Cancer treatment reports.

Tumor Mapping: New Rationales, Adjusted Techniques, Expanded Applications

S. Vogl, J. Cinberg, S. Katlein, 1983, The Laryngoscope.

Carboplatin in advanced, refractory germ cell neoplasms: a phase II Eastern Cooperative Oncology Group Study.

D. Trump, P. Elson, S. Vogl, 1987, Cancer treatment reports.

Phase II trial of cisplatin in advanced gastric cancer.

P. Engstrom, J. Bennett, S. Vogl, 1984, Cancer treatment reports.

Stage II benign cystic teratoma with malignant squamous degeneration.

S. Vogl, V. Seltzer, 1985, New York state journal of medicine.

Adriamycin and cis-diamminedichloroplatinum in the treatment of metastatic endometrial adenocarcinoma.

S. Vogl, V. Seltzer, B. Kaplan, 1984, Gynecologic oncology.

Adjuvant ovarian suppression for resected breast cancer: 2017 critical assessment

S. Vogl, 2017, Breast Cancer Research and Treatment.

Combination Chemotherapy of Advanced Ovarian Cancer with Hexamethylmelamine, cis–Platinum, and Doxorubicin After Failure of Prior Therapy

J. Arseneau, N. Einhorn†, S. Vogl, 1980, Obstetrics and gynecology.

Ovarian cancer. Effective treatment after alkylating-agent failure.

S. Vogl, B. Kaplan, M. Moukhtar, 1979, JAMA.

Phase II study of PALA, amsacrine, teniposide, and zinostatin in small cell lung carcinoma (EST 2579).

D. Ettinger, D. Tritchler, J. Ruckdeschel, 1984, Cancer treatment reports.

Chemotherapy for inoperable, non-small cell bronchogenic carcinoma: EST 2575, generation II.

M. Cohen, J. Ruckdeschel, H. Lerner, 1981, Cancer treatment reports.

Doxorubicin and cisplatin in the treatment of advanced mixed mesodermal uterine sarcoma.

M. Spitzer, S. Vogl, V. Seltzer, 1984, Cancer treatment reports.